Sec. 705. EXCLUDING ABUSE-DETERRENT FORMULATIONS OF PRESCRIPTION DRUGS FROM THE MEDICAID ADDITIONAL REBATE REQUIREMENT FOR NEW FORMULATIONS OF PRESCRIPTION DRUGS
118 words·~1 min read·
/statute-compilations/comps-12178/sec-705A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 705 EXCLUDING ABUSE-DETERRENT FORMULATIONS OF PRESCRIPTION DRUGS FROM THE MEDICAID ADDITIONAL REBATE REQUIREMENT FOR NEW FORMULATIONS OF PRESCRIPTION DRUGS ###
(a)In general The last sentence of section 1927(c)(2)(C) of the Social Security Act (42 U.S.C. 1396r-8(c)(2)(C)) is amended by inserting before the period at the end the following: “, but does not include an abuse-deterrent formulation of the drug (as determined by the Secretary), regardless of whether such abuse-deterrent formulation is an extended release formulation”. ###
(b)Effective Date **[**[42 U.S.C. 1396r-8 note](/us/usc/t42/s1396r-8)**]** The amendment made by subsection
(a)shall apply to drugs that are paid for by a State in calendar quarters beginning on or after the date of the enactment of this Act.
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 705
EXCLUDING ABUSE-DETERRENT FORMULATIONS OF PRESCRIPTION DRUGS FROM THE MEDICAID ADDITIONAL REBATE REQUIREMENT FOR NEW FORMULATIONS OF PRESCRIPTION DRUGS
Cites 1Cited by 0 across 0 sources